Trial intelligence / Profile preview

Carnosine in Gulf War Illness

NCT00810368Phase 2Completed

Sponsor
Georgetown University
Start
Aug 2008
Primary completion
Jul 2012
Modality
Peptides, Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in Gulf War illness (GWI) comparing Carnosine treatment group with Placebo control group (2 arms). Primary endpoints: Accuracy on the 2-back working memory task at 12 weeks, Chronic Fatigue Syndrome Severity at 12 weeks and 5 more. Started Aug 2008; status: completed.

02

Drugs

carnosine
03

Conditions

Gulf War illness (GWI)

Beyond the preview

Go deeper on NCT00810368.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00810368.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call